Hey NQ! You still good with the heat on the call towards 2200 or did you decide to flatten out for further re-evaluation? Just curious as to whether or not the action has changed your current directive.
Right before the monthly OpEx. Seeing some really ugly quotes on the ATM and slightly OTM ES calls in the illiquid overnight session. Obviously, looks like blow outs in the other direction now. Crazier by the day.
Darn, clinical trial is going well. Wonder long before they roll it out officially. Is this a sell the news event? Hmm...
Trailing stop hit 8958.00. I would have gotten out earlier, say 8942, but I was blogging. I'm such an idiot.
The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir. “The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital. https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/